11:27 EDT MAKO MAKO Surgical recall already disclosed, looks minor, says Piper Jaffray
Piper Jaffray says MAKO Surgical's class 2 software recall announced by the FDA had been previously disclosed, and that the issue looks minor. Piper says MAKO management does not expect the issue to impact Q4 volumes. The firm reiterates an Overweight rating on the stock with a $28 price target
large short position.I think this was a negative message that did not get any attention when it first came out,so they rehashed the notice. they are ruthless.Your niave IF YOU DONT THINK THEY COULD PULL IT OFF .FOUR HUNDRED THOUSAND SHARES DROPPED THE STOCK TO 13.20 .
Let's see would this be the same Piper Jaffray that handled the recent stock issuance; yeah, the one with the leak before announcement that saw some preferred customers making a ton going short for the day??
Maybe to a small degree. Just a software update and test that the hospital can schedule around their cases. Each of the last three years there's been a Q3 dip followed by an uptick in Q4 as MAKO has again forecast for Q4 2012.